Tumor-Infiltrating Mast Cells Confer Resistance to Immunotherapy in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) exhibits an immunosuppressive tumor microenvironment (TME) contributing to its therapeutic resistance. Researchers reported that mast cells infiltrating the PDAC TME fostered this immunosuppression and desmoplasia.